Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease
Sponsor: The University of Queensland
Summary
Chronic kidney disease (CKD) affects millions, especially in low- and middle-income countries, where many die early due to lack of treatment. One group of medicines, called SGLT2 inhibitors (SGLT2i), have been shown to slow down kidney damage and reduce the risk of heart-related deaths. The IMPLEMENT-CKD project will work with communities in Thailand, Fiji and Samoa to make it easier for people with CKD or type 2 diabetes to get these life-saving medicines as part of their regular care.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1390
Start Date
2027-07-01
Completion Date
2030-08-01
Last Updated
2026-10-02
Healthy Volunteers
No
Interventions
Implementation of recommendations
The study will be organised into three periods: * A pre-implementation phase - co-design implementation strategies development in each region; * An implementation phase - initiation of SGT2i and evaluation; * A post-implementation phase - consolidate learnings and dissemination for scaling up
Locations (3)
Ministry of Health, Fiji
Suva, Fiji
Department of Health, Samoa
Apia, Samoa
Chulalongkorn University
Bangkok, Thailand